INTCHAINS GROUP LTD-ADR (ICG) Fundamental Analysis & Valuation

NASDAQ:ICG • US45828E1047

Current stock price

1.238 USD
+0.01 (+0.67%)
Last:

This ICG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ICG Profitability Analysis

1.1 Basic Checks

  • ICG had positive earnings in the past year.
  • The reported net income has been mixed in the past 5 years: ICG reported negative net income in multiple years.
  • In multiple years ICG reported negative operating cash flow during the last 5 years.
ICG Yearly Net Income VS EBIT VS OCF VS FCFICG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

  • ICG's Return On Assets of 8.02% is fine compared to the rest of the industry. ICG outperforms 78.26% of its industry peers.
  • ICG has a Return On Equity of 8.31%. This is in the better half of the industry: ICG outperforms 69.57% of its industry peers.
Industry RankSector Rank
ROA 8.02%
ROE 8.31%
ROIC N/A
ROA(3y)13.09%
ROA(5y)26.31%
ROE(3y)13.44%
ROE(5y)28.42%
ROIC(3y)N/A
ROIC(5y)N/A
ICG Yearly ROA, ROE, ROICICG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • The Profit Margin of ICG (35.44%) is better than 93.04% of its industry peers.
  • In the last couple of years the Profit Margin of ICG has declined.
  • In the last couple of years the Operating Margin of ICG has declined.
  • Looking at the Gross Margin, with a value of 36.93%, ICG is in line with its industry, outperforming 40.87% of the companies in the same industry.
  • ICG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 35.44%
GM 36.93%
OM growth 3Y-74.9%
OM growth 5YN/A
PM growth 3Y-36.46%
PM growth 5YN/A
GM growth 3Y-13.15%
GM growth 5Y25.4%
ICG Yearly Profit, Operating, Gross MarginsICG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

8

2. ICG Health Analysis

2.1 Basic Checks

  • ICG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for ICG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ICG Yearly Shares OutstandingICG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICG Yearly Total Debt VS Total AssetsICG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 9.52 indicates that ICG is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of ICG (9.52) is better than 69.57% of its industry peers.
  • ICG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.52
ROIC/WACCN/A
WACC10.1%
ICG Yearly LT Debt VS Equity VS FCFICG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • ICG has a Current Ratio of 16.53. This indicates that ICG is financially healthy and has no problem in meeting its short term obligations.
  • ICG's Current ratio of 16.53 is amongst the best of the industry. ICG outperforms 96.52% of its industry peers.
  • A Quick Ratio of 13.29 indicates that ICG has no problem at all paying its short term obligations.
  • ICG has a better Quick ratio (13.29) than 96.52% of its industry peers.
Industry RankSector Rank
Current Ratio 16.53
Quick Ratio 13.29
ICG Yearly Current Assets VS Current LiabilitesICG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

0

3. ICG Growth Analysis

3.1 Past

  • ICG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.15%.
EPS 1Y (TTM)-46.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-850%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.15%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y45.31%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year75.98%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ICG Yearly Revenue VS EstimatesICG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
ICG Yearly EPS VS EstimatesICG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

0

4. ICG Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 123.80, ICG can be considered very expensive at the moment.
  • ICG's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 25.70, ICG is valued quite expensively.
  • The Price/Forward Earnings ratio is 83.60, which means the current valuation is very expensive for ICG.
  • Based on the Price/Forward Earnings ratio, ICG is valued a bit more expensive than the industry average as 61.74% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of ICG to the average of the S&P500 Index (23.84), we can say ICG is valued expensively.
Industry RankSector Rank
PE 123.8
Fwd PE 83.6
ICG Price Earnings VS Forward Price EarningsICG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICG Per share dataICG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.73
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ICG Dividend Analysis

5.1 Amount

  • No dividends for ICG!.
Industry RankSector Rank
Dividend Yield 0%

ICG Fundamentals: All Metrics, Ratios and Statistics

INTCHAINS GROUP LTD-ADR

NASDAQ:ICG (3/13/2026, 8:00:02 PM)

1.238

+0.01 (+0.67%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners0.51%
Inst Owner Change132.27%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap74.74M
Revenue(TTM)N/A
Net Income(TTM)91.69M
Analysts80
Price Target3.57 (188.37%)
Short Float %0.93%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)774.98%
Min EPS beat(2)42.23%
Max EPS beat(2)1507.72%
EPS beat(4)2
Avg EPS beat(4)338.39%
Min EPS beat(4)-136%
Max EPS beat(4)1507.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-71.04%
Min Revenue beat(2)-83%
Max Revenue beat(2)-59.09%
Revenue beat(4)1
Avg Revenue beat(4)-42.18%
Min Revenue beat(4)-83%
Max Revenue beat(4)9.68%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 123.8
Fwd PE 83.6
P/S 1.98
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)0.01
EY0.81%
EPS(NY)0.01
Fwd EY1.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.62
BVpS2.66
TBVpS2.65
PEG (NY)2.73
PEG (5Y)N/A
Graham Number0.77
Profitability
Industry RankSector Rank
ROA 8.02%
ROE 8.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 35.44%
GM 36.93%
FCFM N/A
ROA(3y)13.09%
ROA(5y)26.31%
ROE(3y)13.44%
ROE(5y)28.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-74.9%
OM growth 5YN/A
PM growth 3Y-36.46%
PM growth 5YN/A
GM growth 3Y-13.15%
GM growth 5Y25.4%
F-ScoreN/A
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.53
Quick Ratio 13.29
Altman-Z 9.52
F-ScoreN/A
WACC10.1%
ROIC/WACCN/A
Cap/Depr(3y)579.46%
Cap/Depr(5y)422.67%
Cap/Sales(3y)21.87%
Cap/Sales(5y)13.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-850%
EPS Next Y45.31%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.15%
Revenue Next Year75.98%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-192.55%
EBIT growth 3Y-80.82%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-169.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2836.55%
OCF growth 3YN/A
OCF growth 5YN/A

INTCHAINS GROUP LTD-ADR / ICG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTCHAINS GROUP LTD-ADR?

ChartMill assigns a fundamental rating of 3 / 10 to ICG.


What is the valuation status for ICG stock?

ChartMill assigns a valuation rating of 0 / 10 to INTCHAINS GROUP LTD-ADR (ICG). This can be considered as Overvalued.


What is the profitability of ICG stock?

INTCHAINS GROUP LTD-ADR (ICG) has a profitability rating of 3 / 10.


How financially healthy is INTCHAINS GROUP LTD-ADR?

The financial health rating of INTCHAINS GROUP LTD-ADR (ICG) is 8 / 10.